vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $37.2M, roughly 1.1× Organogenesis Holdings Inc.). On growth, Cambium Networks Corp posted the faster year-over-year revenue change (-23.2% vs -57.1%). Over the past eight quarters, Cambium Networks Corp's revenue compounded faster (-27.2% CAGR vs -46.5%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CMBM vs ORGO — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.1× larger
CMBM
$40.3M
$37.2M
ORGO
Growing faster (revenue YoY)
CMBM
CMBM
+33.9% gap
CMBM
-23.2%
-57.1%
ORGO
Faster 2-yr revenue CAGR
CMBM
CMBM
Annualised
CMBM
-27.2%
-46.5%
ORGO

Income Statement — Q4 FY2024 vs Q1 FY2026

Metric
CMBM
CMBM
ORGO
ORGO
Revenue
$40.3M
$37.2M
Net Profit
$-7.2M
Gross Margin
36.6%
30.8%
Operating Margin
-28.4%
-185.1%
Net Margin
-17.9%
Revenue YoY
-23.2%
-57.1%
Net Profit YoY
71.0%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$150.9M
Q2 25
$101.0M
Q1 25
$86.7M
Q4 24
$40.3M
$126.7M
Q3 24
$44.7M
$115.2M
Q2 24
$45.2M
$130.2M
Net Profit
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
Q2 25
$-9.4M
Q1 25
$-18.8M
Q4 24
$-7.2M
$7.7M
Q3 24
$-34.5M
$12.3M
Q2 24
$-14.2M
$-17.0M
Gross Margin
CMBM
CMBM
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
36.6%
75.5%
Q3 24
43.6%
76.7%
Q2 24
32.5%
77.6%
Operating Margin
CMBM
CMBM
ORGO
ORGO
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-12.5%
Q1 25
-30.9%
Q4 24
-28.4%
8.1%
Q3 24
-69.6%
5.4%
Q2 24
-27.2%
-10.7%
Net Margin
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
14.3%
Q2 25
-9.3%
Q1 25
-21.7%
Q4 24
-17.9%
6.1%
Q3 24
-77.3%
10.7%
Q2 24
-31.5%
-13.1%
EPS (diluted)
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$-0.26
$0.05
Q3 24
$-1.22
$0.09
Q2 24
$-0.51
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-3.2M
Total Assets
$173.7M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$67.6M
Q3 24
$67.6M
$62.3M
Q2 24
$68.9M
$63.8M
Stockholders' Equity
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
$300.1M
Q3 25
$255.1M
Q2 25
$233.2M
Q1 25
$242.9M
Q4 24
$-3.2M
$262.9M
Q3 24
$1.9M
$278.5M
Q2 24
$34.1M
$263.5M
Total Assets
CMBM
CMBM
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$509.8M
Q2 25
$461.1M
Q1 25
$467.4M
Q4 24
$173.7M
$497.9M
Q3 24
$194.3M
$446.3M
Q2 24
$221.1M
$443.2M
Debt / Equity
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
36.12×
0.22×
Q2 24
2.02×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
ORGO
ORGO
Operating Cash FlowLast quarter
$-10.4M
Free Cash FlowOCF − Capex
$-10.8M
FCF MarginFCF / Revenue
-26.8%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
$39.4M
Q3 25
$3.1M
Q2 25
$-32.9M
Q1 25
$-19.9M
Q4 24
$-10.4M
$10.9M
Q3 24
$8.9M
$8.7M
Q2 24
$2.4M
$4.7M
Free Cash Flow
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$-10.8M
$7.6M
Q3 24
$6.8M
$6.1M
Q2 24
$87.0K
$2.9M
FCF Margin
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
-26.8%
6.0%
Q3 24
15.2%
5.3%
Q2 24
0.2%
2.2%
Capex Intensity
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
1.1%
2.7%
Q3 24
4.8%
2.2%
Q2 24
5.1%
1.4%
Cash Conversion
CMBM
CMBM
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons